CA2485298A1 - Composes substitues de pyrazolyl utilises dans le traitement des inflammations - Google Patents

Composes substitues de pyrazolyl utilises dans le traitement des inflammations Download PDF

Info

Publication number
CA2485298A1
CA2485298A1 CA002485298A CA2485298A CA2485298A1 CA 2485298 A1 CA2485298 A1 CA 2485298A1 CA 002485298 A CA002485298 A CA 002485298A CA 2485298 A CA2485298 A CA 2485298A CA 2485298 A1 CA2485298 A1 CA 2485298A1
Authority
CA
Canada
Prior art keywords
inflammation
substituted pyrazolyl
treatment
pyrazolyl compounds
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002485298A
Other languages
English (en)
Other versions
CA2485298C (fr
Inventor
Patrick Lennon
Dominique Bonafoux
David S. Oburn
Serge G. Wolfson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia LLC
Original Assignee
Pharmacia Corporation
Patrick Lennon
Dominique Bonafoux
David S. Oburn
Serge G. Wolfson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2002/029774 external-priority patent/WO2003024935A2/fr
Application filed by Pharmacia Corporation, Patrick Lennon, Dominique Bonafoux, David S. Oburn, Serge G. Wolfson filed Critical Pharmacia Corporation
Publication of CA2485298A1 publication Critical patent/CA2485298A1/fr
Application granted granted Critical
Publication of CA2485298C publication Critical patent/CA2485298C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002485298A 2002-05-09 2003-03-19 Composes substitues de pyrazolyl utilises dans le traitement des inflammations Expired - Fee Related CA2485298C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US37909002P 2002-05-09 2002-05-09
US60/379,090 2002-05-09
USPCT/US02/29774 2002-09-19
PCT/US2002/029774 WO2003024935A2 (fr) 2001-09-19 2002-09-19 Composes de pyrazolyle substitues destines au traitement de l'inflammation
PCT/US2003/008917 WO2003095430A1 (fr) 2002-05-09 2003-03-19 Composes substitues de pyrazolyl utilises dans le traitement des inflammations

Publications (2)

Publication Number Publication Date
CA2485298A1 true CA2485298A1 (fr) 2003-11-20
CA2485298C CA2485298C (fr) 2008-03-11

Family

ID=29422601

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002485298A Expired - Fee Related CA2485298C (fr) 2002-05-09 2003-03-19 Composes substitues de pyrazolyl utilises dans le traitement des inflammations

Country Status (5)

Country Link
EP (1) EP1501805A1 (fr)
AU (1) AU2003220483A1 (fr)
CA (1) CA2485298C (fr)
MX (1) MXPA04010952A (fr)
WO (1) WO2003095430A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2502429A1 (fr) 2002-10-31 2004-05-21 Amgen Inc. Agents anti-inflammatoires
TW200616967A (en) 2004-06-24 2006-06-01 Smithkline Beecham Corp Novel indazole carboxamides and their use
PE20060748A1 (es) 2004-09-21 2006-10-01 Smithkline Beecham Corp Derivados de indolcarboxamida como inhibidores de quinasa ikk2
JP5059756B2 (ja) 2005-06-30 2012-10-31 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 化合物
US8063071B2 (en) 2007-10-31 2011-11-22 GlaxoSmithKline, LLC Chemical compounds
PE20081889A1 (es) 2007-03-23 2009-03-05 Smithkline Beecham Corp Indol carboxamidas como inhibidores de ikk2
US8354539B2 (en) 2009-03-10 2013-01-15 Glaxo Group Limited Indole derivatives as IKK2 inhibitors
US9079919B2 (en) 2011-05-27 2015-07-14 Hoffmann-La Roche Inc. Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as BACE1 and/or BACE2 inhibitors
WO2023172846A1 (fr) * 2022-03-08 2023-09-14 Flare Therapeutics Inc. Agonistes inverses de pparg et leurs utilisations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO118291B1 (ro) * 1993-11-30 2003-04-30 Searle & Co Derivati de pirazol 1,3,4,5 - tetrasubstituiti si compozitie farmaceutica care ii contine

Also Published As

Publication number Publication date
MXPA04010952A (es) 2005-01-25
WO2003095430A1 (fr) 2003-11-20
CA2485298C (fr) 2008-03-11
EP1501805A1 (fr) 2005-02-02
AU2003220483A1 (en) 2003-11-11

Similar Documents

Publication Publication Date Title
CA2460939A1 (fr) Composes de pyrazolyl substitues pour le traitement de l'inflammation
WO2003024935A3 (fr) Composes de pyrazolyle substitues destines au traitement de l'inflammation
MXPA04002070A (es) Compuestos de indazol sustituidos para el tratamiento de la inflamacion.
WO2003037886A3 (fr) Derives de carboxamide heteroaromatique destines au traitement des inflammations
CA2461567A1 (fr) Composes substitues de sulfamide benzene de pyrazolyl destines au traitement des inflammations
WO2004007457A3 (fr) Derives de benzylamine substitues et procedes d'utilisation
WO2002014311A3 (fr) Composes d'uree et leurs procedes d'utilisation
WO2002064594A3 (fr) Pyrido-pyrimidines substituees en position 6
CA2534570A1 (fr) Derives 2,3-dihydro-1h-isoindol-1-one substitues et techniques d'utilisation
MXPA05012025A (es) Imidazo y tiazolopiridinas como inhibidores de cinasa jak3.
WO2004005279A3 (fr) Derives d'amide anthranilique substitues et leurs procedes d'utilisation
WO2004078144A3 (fr) Composes diphenylethylene et leurs utilisations
WO2005046603A3 (fr) Composes pyridiniques
HK1069169A1 (en) Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
WO2003053368A3 (fr) Derives de chalcone et leur utilisation dans le traitement de maladies
BR0307796A (pt) Derivados tricìclicos de pirazol para o tratamento de inflamação
RS60503A (en) Substituted alkylamine derivatives and methods of use
CA2534571A1 (fr) Derives substitues de l'isoquinoline, et leurs methodes d'utilisation
MXPA05009304A (es) Derivados de indol utiles para el tratamiento de enfermedades.
AU2003209118A1 (en) Aryl ureas as kinase inhibitors
WO2004106293A3 (fr) Composes tricycliques a base d'oxazolo[4,5-b]pyridine condensee a un imidazo et de thiazolo[4,5-b]pyridine condensee a un imidazo, et compositions pharmaceutiques renfermant ceux-ci
WO2003053359A3 (fr) 1,3-bis-(phenyl-substitue)-2-propyne-1-ones et leur utilisation pour le traitement d'affections
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
WO2003087062A3 (fr) Composes heterocycliques, procede de preparation de ces composes et compositions pharmaceutiques les contenant, et utilisations en medecine
CA2485298A1 (fr) Composes substitues de pyrazolyl utilises dans le traitement des inflammations

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed